ASMPT Limited
ASMPT Limited (ASMVY) Financial Performance & Income Statement Overview
Analyze ASMPT Limited (ASMVY) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
ASMPT Limited (ASMVY) Income Statement & Financial Overview
Review ASMPT Limited ASMVY income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $3.12B | $6.75B | $0.00 | $3.34B |
| Cost of Revenue | $1.85B | $0.00 | $0.00 | $3.83B |
| Gross Profit | $1.28B | $0.00 | $0.00 | $2.65B |
| Gross Profit Ratio | $0.41 | $0.00 | $0.00 | $0.79 |
| R&D Expenses | $491.40M | $0.00 | $0.00 | $993.15M |
| SG&A Expenses | $626.79M | $0.00 | $0.00 | $668.68M |
| Operating Expenses | $1.12B | $0.00 | $0.00 | $2.28B |
| Total Costs & Expenses | $2.96B | $3.44B | $0.00 | $3.21B |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $105.54M |
| Depreciation & Amortization | $116.12M | $347.37M | $0.00 | $355.15M |
| EBITDA | $276.05M | $488.34M | $0.00 | $898.84M |
| EBITDA Ratio | $0.09 | $0.07 | $0.00 | $0.27 |
| Operating Income | $159.93M | $140.98M | $0.00 | $377.19M |
| Operating Income Ratio | $0.05 | $0.02 | $0.00 | $0.11 |
| Other Income/Expenses (Net) | -$53.20M | -$106.18M | $0.00 | $60.95M |
| Income Before Tax | $106.73M | $34.80M | $0.00 | $438.14M |
| Income Before Tax Ratio | $0.03 | $0.005 | $0.00 | $0.13 |
| Income Tax Expense | $24.14M | $18.58M | $0.00 | $140.73M |
| Net Income | $83.64M | $0.00 | $0.00 | $314.97M |
| Net Income Ratio | $0.03 | $0.00 | $0.00 | $0.09 |
| EPS | $0.20 | $0.01 | $0.06 | $0.76 |
| Diluted EPS | $0.20 | $0.01 | $0.06 | $0.76 |
| Weighted Avg Shares Outstanding | $418.19M | $416.46M | $414.17M | $409.25M |
| Weighted Avg Shares Outstanding (Diluted) | $416.45M | $418.78M | $415.76M | $409.25M |
Financial performance has remained strong, with revenue growing from $3.34B in Q2 2024 to $3.12B in Q1 2025. Gross profit continued to perform well, with margins at 41% in the latest quarter. Operating income reached $159.93M in Q1 2025, holding a steady 5% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $276.05M. Net income rose to $83.64M, keeping EPS at $0.20. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan